MGC Pharma submits patent application for CimetrA to European IP Office
LONDON: MGC Pharmaceuticals Ltd (ASX: MXC) announced the successful submission of a patent application for CimetrA to the Slovenian Intellectual Property Office (SIPO), assigned to...
MGC Pharma to acquire Israel based MediCaNL for $6.0 million in shares
LONDON: MGC Pharmaceuticals Ltd announced the acquisition of 100% of the issued share capital of MediCaNL Inc. MediCaNL Inc is the holding company of MediCaNL...
MGC Pharma signed binding term sheet to acquire Medicinal Cannabis Clinic
PERTH: MGC Pharmaceuticals Ltd, a European based bio-pharma company has signed a binding term sheet with Cannvalate Pty Ltd (CVL) to acquire 100% of the...